Table 1 Baseline clinical characteristics of the study population
TEA group (n = 57) | LEA group (n = 63) | *P | |
|---|---|---|---|
Age (years) | 55.37 ± 13.3 | 52.73 ± 13.33 | 0.281 |
Height (cm) | 167.77 ± 7.87 | 166.4 ± 10.705 | 0.428 |
Weight (kg) | 69.39 ± 12.44 | 7 4.24 ± 15.83 | 0.066 |
Body mass index (kg/m2) | 24.6 ± 3.58 | 25.14 ± 4.9 | 0.492 |
Gender (F/M) | |||
Female | 7 (12.3) | 9 (14.3) | 0.747 |
Male | 50 (87.7) | 54 (85.7) | |
ASA status | |||
I | 6 (10.5) | 10 (15.9) | 0.39 |
II | 40 (70.2) | 36 (57.1) | 0.139 |
III | 11 (19.3) | 17 (27) | 0.32 |
Charlson comorbidity index | |||
0 | 6 (10.5) | 9 (14.3) | 0.534 |
1- 2 | 38 (66.7) | 40 (63.5) | 0.716 |
> 2 | 13 (22.8) | 14 (22.2) | 0.939 |